Beatty GL, Gladney WL. Immune escape mechanisms as a guide for cancer immunotherapy. Clin Cancer Res. 2015;21:687–92.

Article  CAS  PubMed  Google Scholar 

Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017;168:707–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martyn I, Kanno TY, Ruzo A, Siggia ED, Brivanlou AH. Self-organization of a human organizer by combined Wnt and Nodal signalling. Nature. 2018;558:132–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Katoh M, Katoh M. Molecular genetics and targeted therapy of WNT-related human diseases (Review). Int J Mol Med. 2017;40:587–606.

CAS  PubMed  PubMed Central  Google Scholar 

Niehrs C. The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol. 2012;13:767–79.

Article  CAS  PubMed  Google Scholar 

Torres MA, Yang-Snyder JA, Purcell SM, DeMarais AA, McGrew LL, Moon RT. Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class and by a dominant negative cadherin in early Xenopus development. J Cell Biol. 1996;133:1123–37.

Article  CAS  PubMed  Google Scholar 

Chu HY, Chen Z, Wang L, Zhang ZK, Tan X, Liu S, et al. Dickkopf-1: a promising target for cancer immunotherapy. Front Immunol. 2021;12:658097.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ren Q, Chen J, Liu Y. LRP5 and LRP6 in Wnt signaling: similarity and divergence. Front Cell Dev Biol. 2021;9:670960.

Article  PubMed  PubMed Central  Google Scholar 

D’Amico L, Mahajan S, Capietto AH, Yang Z, Zamani A, Ricci B, et al. Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer. J Exp Med. 2016;213:827–40.

Article  PubMed  PubMed Central  Google Scholar 

Haas MS, Kagey MH, Heath H, Schuerpf F, Rottman JB, Newman W. mDKN-01, a novel anti-DKK1 mAb, enhances innate immune responses in the tumor microenvironment. Mol Cancer Res. 2021;19:717–25.

Article  CAS  PubMed  Google Scholar 

Wise DR, Schneider JA, Armenia J, Febles VA, McLaughlin B, Brennan R, et al. Dickkopf-1 can lead to immune evasion in metastatic castration-resistant prostate cancer. JCO Precis Oncol. 2020;4. https://doi.org/10.1200/PO.20.00097.

Alfaleh MA, Alsaab HO, Mahmoud AB, Alkayyal AA, Jones ML, Mahler SM, et al. Phage display derived monoclonal antibodies: from bench to bedside. Front Immunol. 2020;11:1986.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoose A, Vellacott R, Storch M, Freemont PS, Ryadnov MG. DNA synthesis technologies to close the gene writing gap. Nat Rev Chem. 2023;7:144–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoffmann SA, Diggans J, Densmore D, Dai J, Knight T, Leproust E, et al. Safety by design: Biosafety and biosecurity in the age of synthetic genomics. iScience. 2023;26:106165.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan TZ, Garg P, Wang L, Willis JR, Kwan E, Hernandez AGL, et al. Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries. MAbs. 2022;14:2002236.

Article  PubMed  Google Scholar 

Laustsen AH, Greiff V, Karatt-Vellatt A, Muyldermans S, Jenkins TP. Animal immunization, in vitro display technologies, and machine learning for antibody discovery. Trends Biotechnol. 2021;39:1263–73.

Article  CAS  PubMed  Google Scholar 

Bailly M, Mieczkowski C, Juan V, Metwally E, Tomazela D, Baker J, et al. Predicting antibody developability profiles through early stage discovery screening. MAbs. 2020;12:1743053.

Article  PubMed  PubMed Central  Google Scholar 

Liu G, Zeng H, Mueller J, Carter B, Wang Z, Schilz J, et al. Antibody complementarity determining region design using high-capacity machine learning. Bioinformatics. 2020;36:2126–33.

Article  CAS  PubMed  Google Scholar 

Ito T, Nguyen TD, Saito Y, Kurumida Y, Nakazawa H, Kawada S, et al. Selection of target-binding proteins from the information of weakly enriched phage display libraries by deep sequencing and machine learning. MAbs. 2023;15:2168470.

Article  PubMed  PubMed Central  Google Scholar 

Jian JW, Chen HS, Chiu YK, Peng HP, Tung CP, Chen IC, et al. Effective binding to protein antigens by antibodies from antibody libraries designed with enhanced protein recognition propensities. MAbs. 2019;11:373–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen Y, Voigt A, Leng X, Rodriguez AA, Nguyen CQ. A current and future perspective on T cell receptor repertoire profiling. Front Genet. 2023;14:1159109.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Minkoff BB, Blatz JM, Choudhury FA, Benjamin D, Shohet JL, Sussman MR. Plasma-generated OH radical production for analyzing three-dimensional structure in protein therapeutics. Sci Rep. 2017;7:12946.

Article  PubMed  PubMed Central  Google Scholar 

Houschyar KS, Tapking C, Borrelli MR, Popp D, Duscher D, Maan ZN, et al. Wnt pathway in bone repair and regeneration - what do we know so far. Front Cell Dev Biol. 2018;6:170.

Article  PubMed  Google Scholar 

Ponzetti M, Rucci N. Osteoblast differentiation and signaling: established concepts and emerging topics. Int J Mol Sci. 2021;22:6651.

Bernar A, Gebetsberger JV, Bauer M, Streif W, Schirmer M. Optimization of the Alizarin Red S assay by enhancing mineralization of osteoblasts. Int J Mol Sci. 2022;24:723.

Chae WJ, Bothwell ALM. Dickkopf1: an immunomodulatory ligand and Wnt antagonist in pathological inflammation. Differentiation. 2019;108:33–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan IS, Ewald AJ. The changing role of natural killer cells in cancer metastasis. J Clin Invest 2022;132:e143762.

Wise DR, Pachynski RK, Denmeade SR, Aggarwal RR, Deng J, Febles VA, et al. A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Prostate Cancer Prostatic Dis. 2024. https://doi.org/10.1038/s41391-024-00798-z.

Yuan S, Hoggard NK, Kantake N, Hildreth BE, 3rd, Rosol TJ. Effects of Dickkopf-1 (DKK-1) on prostate cancer growth and bone metastasis. Cells. 2023;12:2695.

Rinella L, Fiorentino G, Compagno M, Grange C, Cedrino M, Marano F, et al. Dickkopf-1 (DKK1) drives growth and metastases in castration-resistant prostate cancer. Cancer Gene Ther. 2024:31;1266–1279.

Faccio R, Lee S, Ricci B, Tran J, Ye J, Clever D, et al. Cancer-associated fibroblast-derived Dickkopf-1 suppresses NK cell cytotoxicity in breast cancer. Research Square; 2024. https://doi.org/10.21203/rs.3.rs-4202878/v1.

Kasoha M, Steinbach AK, Bohle RM, Linxweiler B, Haj Hamoud B, Doerk M, et al. Dkk1 as a prognostic marker for neoadjuvant chemotherapy response in breast cancer patients. Cancers. 2024;16:419.

Yao L, Zhang D, Zhao X, Sun B, Liu Y, Gu Q, et al. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype. J Cell Mol Med. 2016;20:1673–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen L, Wu X, Tan J, Gu M, Teng Y, Wang Z, et al. Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer. Onco Targets Ther. 2017;10:3545–56.

Article  PubMed  PubMed Central  Google Scholar 

Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:1461–73.

Article  CAS  PubMed  Google Scholar 

Hong SA, Yoo SH, Lee HH, Sun S, Won HS, Kim O, et al. Prognostic value of Dickkopf-1 and ss-catenin expression in advanced gastric cancer. BMC Cancer. 2018;18:506.

Article  PubMed  PubMed Central  Google Scholar 

Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J, et al. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene. 2006;25:4116–21.

Article  CAS  PubMed